Caribou Biosciences Inc.

NASDAQ: CRBU · Real-Time Price · USD
1.97
-0.03 (-1.50%)
At close: Aug 15, 2025, 3:59 PM
1.98
0.51%
After-hours: Aug 15, 2025, 05:38 PM EDT

Caribou Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-164.26M -147.86M -149.1M -148.12M -123.44M -115.26M -102.07M -94.55M -111.2M -108.38M -99.42M -90.91M -85.24M -72.85M -66.92M -63.15M -50.11M -37.67M
Depreciation & Amortization
4.69M 4.38M 3.93M 4.72M 5.12M 4.88M 4.76M 3.29M 2.16M 1.9M 1.62M 1.39M 1.2M 1.07M 984K 931K 897K 895K
Stock-Based Compensation
14.99M 16.6M 16.71M 16.35M 15.76M 14.61M 13.75M 13.29M 12.49M 11.82M 11.72M 10.19M 8.46M 6.13M 3.45M 2.1M 1.42M 1.11M
Other Working Capital
-5.23M -4.11M -4.51M 1.99M -17.83M -16.04M -14.76M -17.94M 1.8M -995K -2.43M -2.71M -1.84M -2.8M 31.13M 31.7M 32.27M 29.54M
Other Non-Cash Items
17.78M -5.89M -5.43M 3.42M 5.29M 9.09M 7.65M -1.86M -668K -1.03M -584K -1.57M -1.02M 659K 2.16M 9.95M 7.47M -1.52M
Deferred Income Tax
n/a n/a n/a -5.5M -7.94M -10.06M -10.06M -4.66M -2.22M -95K -95K 321K 321K -1.26M -1.25M -1.57M -1.5M 73K
Change in Working Capital
-6.31M -4.95M -4.3M 5.02M -15.03M -5.8M -7.32M -12.47M 8.89M -1.46M -4.2M -6.73M -3.62M -8.26M 29.07M 32.53M 28.9M 33.46M
Operating Cash Flow
-133.11M -137.72M -138.2M -124.11M -120.24M -102.56M -93.29M -96.96M -90.54M -97.23M -90.97M -87.31M -79.9M -74.5M -32.52M -19.21M -12.93M -3.66M
Capital Expenditures
-2.65M -4.47M -4.88M -6.64M -10.72M -11.03M -11.61M -11.39M -8.29M -8.36M -7.05M -5.68M -5.96M -3.82M -3.12M -3.04M -1.12M -689K
Cash Acquisitions
n/a n/a n/a 29.2M 92.92M 79.3M 56.57M 27.67M -35.75M -10.78M 11.95M 11.65M 11.35M n/a n/a n/a n/a n/a
Purchase of Investments
-201.18M -252.45M -308.1M -336.79M -415.5M -390.01M -394.76M -397.08M -291.99M -304.31M -339.06M -425.83M -355.02M -283.96M -173.28M n/a n/a n/a
Sales Maturities Of Investments
315.23M 366.36M 397.49M 380.55M 372.05M 336.61M 338.19M 372.93M 324.88M 312.23M 252.87M 163.13M 99.01M 39.3M n/a n/a n/a n/a
Other Investing Acitivies
2.84M 1.97M 471K -27.11M -94.55M -80.8M -56.57M -27.67M 35.75M 10.78M -83.34M -256.31M -257.01M -245.66M -174.28M -1.57M -563K -563K
Investing Cash Flow
115.87M 113.03M 86.61M 39.2M -55.79M -65.93M -68.18M -35.54M 24.6M -439K -93.25M -268.38M -261.97M -248.48M -176.4M -3.04M -1.11M -679K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.15M 1.03M 1M 976K 1.38M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
919K 376K 1.53M 689K 1.44M 2.21M 1.58M 1.64M 1.54M 1.66M 2.13M 2.47M 324.5M 323.59M 323.16M 322.81M 269K 834K
Financial Cash Flow
4.58M 4.71M 16.72M 12.82M 147.7M 165.14M 154.3M 154.47M 19.99M 2.79M 2.13M 2.47M 324.5M 324.74M 433.43M 433.05M 110.48M 111.44M
Net Cash Flow
-12.62M -19.98M -34.87M -72.09M -28.33M -3.34M -7.18M 21.97M -45.91M -94.89M -182.08M -353.23M -17.42M 1.75M 224.51M 410.81M 96.44M 107.11M
Free Cash Flow
-135.76M -142.2M -143.08M -130.75M -130.95M -113.58M -104.9M -108.35M -98.84M -105.59M -98.02M -92.99M -85.86M -78.33M -35.64M -22.24M -14.05M -4.35M